Email
Print
Drugs For Schistosomiasis Market - Forecast(2024 - 2030)
1. Drugs For Schistosomiasis Market - Overview
1.1 Definitions and Scope
2. Drugs For Schistosomiasis Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Drugs For Schistosomiasis Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Drugs For Schistosomiasis Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Drugs For Schistosomiasis Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Drugs For Schistosomiasis Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Drugs For Schistosomiasis Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Drugs For Schistosomiasis Market - By Specie Type (Market Size -$Million / $Billion)
8.1 Schistosoma Mansoni
8.2 Schistosoma Japonicum
8.3 Schistosoma Mekongi
1.1 Definitions and Scope
2. Drugs For Schistosomiasis Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Drugs For Schistosomiasis Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Drugs For Schistosomiasis Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Drugs For Schistosomiasis Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Drugs For Schistosomiasis Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Drugs For Schistosomiasis Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Drugs For Schistosomiasis Market - By Specie Type (Market Size -$Million / $Billion)
8.1 Schistosoma Mansoni
8.2 Schistosoma Japonicum
8.3 Schistosoma Mekongi
8.4 Schistosoma Guineensis
8.5 Schistosoma Haematobium
9. Drugs For Schistosomiasis Market - By Site (Market Size -$Million / $Billion)
9.1 Intestinal
9.2 Urogenital
10. Drugs For Schistosomiasis - By Drug Type (Market Size -$Million / $Billion)
10.1 Praziquantel
10.2 Metrifonate
10.3 Biltricide
9. Drugs For Schistosomiasis Market - By Site (Market Size -$Million / $Billion)
9.1 Intestinal
9.2 Urogenital
10. Drugs For Schistosomiasis - By Drug Type (Market Size -$Million / $Billion)
10.1 Praziquantel
10.2 Metrifonate
10.3 Biltricide
10.4 Oxamniquine
11. Drugs For Schistosomiasis- By Geography (Market Size -$Million / $Billion)
11.1 Drugs For Schistosomiasis Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Drugs For Schistosomiasis- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Drugs For Schistosomiasis- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Drugs For Schistosomiasis - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Drugs For Schistosomiasis - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Drugs For Schistosomiasis Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Drugs For Schistosomiasis Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Drugs For Schistosomiasis Market - Key Company List by Country Premium
15. Drugs For Schistosomiasis Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Bayer Ag
15.3 Cbc Pharma
15.4 Egyptian International Pharmaceutical Industry Co Sae
15.5 Merck Co , Inc
15.6 Samarth Pharma Pvt Ltd
15.7 Shin Poong Pharma Co , Ltd
15.8 Shreeji Pharma International
15.9 Taj Pharmaceutical Ltd
15.10 V H Bhagat Pharmaceutical Pvt Ltd
15.11 Vhb Life Science Inc
15.12 Company 12
15.13 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. Drugs For Schistosomiasis Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
11. Drugs For Schistosomiasis- By Geography (Market Size -$Million / $Billion)
11.1 Drugs For Schistosomiasis Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Drugs For Schistosomiasis- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Drugs For Schistosomiasis- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Drugs For Schistosomiasis - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Drugs For Schistosomiasis - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Drugs For Schistosomiasis Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Drugs For Schistosomiasis Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Drugs For Schistosomiasis Market - Key Company List by Country Premium
15. Drugs For Schistosomiasis Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Bayer Ag
15.3 Cbc Pharma
15.4 Egyptian International Pharmaceutical Industry Co Sae
15.5 Merck Co , Inc
15.6 Samarth Pharma Pvt Ltd
15.7 Shin Poong Pharma Co , Ltd
15.8 Shreeji Pharma International
15.9 Taj Pharmaceutical Ltd
15.10 V H Bhagat Pharmaceutical Pvt Ltd
15.11 Vhb Life Science Inc
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Drugs For Schistosomiasis Market - Appendix16.1 Abbreviations
16.2 Sources
17. Drugs For Schistosomiasis Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Drug For Schistosomiasis Market, By Site Market 2023-2030 ($M)1.1 Intestinal Market 2023-2030 ($M) - Global Industry Research
1.2 Urogenital Market 2023-2030 ($M) - Global Industry Research
2.Global Drug For Schistosomiasis Market, By Specie Type Market 2023-2030 ($M)
2.1 Schistosoma Mansoni Market 2023-2030 ($M) - Global Industry Research
2.2 Schistosoma Japonicum Market 2023-2030 ($M) - Global Industry Research
2.3 Schistosoma Mekongi Market 2023-2030 ($M) - Global Industry Research
2.4 Schistosoma Guineensis Market 2023-2030 ($M) - Global Industry Research
2.5 Schistosoma Haematobium Market 2023-2030 ($M) - Global Industry Research
3.Global Drug For Schistosomiasis Market, By Drug Type Market 2023-2030 ($M)
3.1 Praziquantel Market 2023-2030 ($M) - Global Industry Research
3.2 Metrifonate Market 2023-2030 ($M) - Global Industry Research
3.3 Biltricide Market 2023-2030 ($M) - Global Industry Research
3.4 Oxamniquine Market 2023-2030 ($M) - Global Industry Research
4.Global Drug For Schistosomiasis Market, By Site Market 2023-2030 (Volume/Units)
4.1 Intestinal Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Urogenital Market 2023-2030 (Volume/Units) - Global Industry Research
5.Global Drug For Schistosomiasis Market, By Specie Type Market 2023-2030 (Volume/Units)
5.1 Schistosoma Mansoni Market 2023-2030 (Volume/Units) - Global Industry Research
5.2 Schistosoma Japonicum Market 2023-2030 (Volume/Units) - Global Industry Research
5.3 Schistosoma Mekongi Market 2023-2030 (Volume/Units) - Global Industry Research
5.4 Schistosoma Guineensis Market 2023-2030 (Volume/Units) - Global Industry Research
5.5 Schistosoma Haematobium Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global Drug For Schistosomiasis Market, By Drug Type Market 2023-2030 (Volume/Units)
6.1 Praziquantel Market 2023-2030 (Volume/Units) - Global Industry Research
6.2 Metrifonate Market 2023-2030 (Volume/Units) - Global Industry Research
6.3 Biltricide Market 2023-2030 (Volume/Units) - Global Industry Research
6.4 Oxamniquine Market 2023-2030 (Volume/Units) - Global Industry Research
7.North America Drug For Schistosomiasis Market, By Site Market 2023-2030 ($M)
7.1 Intestinal Market 2023-2030 ($M) - Regional Industry Research
7.2 Urogenital Market 2023-2030 ($M) - Regional Industry Research
8.North America Drug For Schistosomiasis Market, By Specie Type Market 2023-2030 ($M)
8.1 Schistosoma Mansoni Market 2023-2030 ($M) - Regional Industry Research
8.2 Schistosoma Japonicum Market 2023-2030 ($M) - Regional Industry Research
8.3 Schistosoma Mekongi Market 2023-2030 ($M) - Regional Industry Research
8.4 Schistosoma Guineensis Market 2023-2030 ($M) - Regional Industry Research
8.5 Schistosoma Haematobium Market 2023-2030 ($M) - Regional Industry Research
9.North America Drug For Schistosomiasis Market, By Drug Type Market 2023-2030 ($M)
9.1 Praziquantel Market 2023-2030 ($M) - Regional Industry Research
9.2 Metrifonate Market 2023-2030 ($M) - Regional Industry Research
9.3 Biltricide Market 2023-2030 ($M) - Regional Industry Research
9.4 Oxamniquine Market 2023-2030 ($M) - Regional Industry Research
10.South America Drug For Schistosomiasis Market, By Site Market 2023-2030 ($M)
10.1 Intestinal Market 2023-2030 ($M) - Regional Industry Research
10.2 Urogenital Market 2023-2030 ($M) - Regional Industry Research
11.South America Drug For Schistosomiasis Market, By Specie Type Market 2023-2030 ($M)
11.1 Schistosoma Mansoni Market 2023-2030 ($M) - Regional Industry Research
11.2 Schistosoma Japonicum Market 2023-2030 ($M) - Regional Industry Research
11.3 Schistosoma Mekongi Market 2023-2030 ($M) - Regional Industry Research
11.4 Schistosoma Guineensis Market 2023-2030 ($M) - Regional Industry Research
11.5 Schistosoma Haematobium Market 2023-2030 ($M) - Regional Industry Research
12.South America Drug For Schistosomiasis Market, By Drug Type Market 2023-2030 ($M)
12.1 Praziquantel Market 2023-2030 ($M) - Regional Industry Research
12.2 Metrifonate Market 2023-2030 ($M) - Regional Industry Research
12.3 Biltricide Market 2023-2030 ($M) - Regional Industry Research
12.4 Oxamniquine Market 2023-2030 ($M) - Regional Industry Research
13.Europe Drug For Schistosomiasis Market, By Site Market 2023-2030 ($M)
13.1 Intestinal Market 2023-2030 ($M) - Regional Industry Research
13.2 Urogenital Market 2023-2030 ($M) - Regional Industry Research
14.Europe Drug For Schistosomiasis Market, By Specie Type Market 2023-2030 ($M)
14.1 Schistosoma Mansoni Market 2023-2030 ($M) - Regional Industry Research
14.2 Schistosoma Japonicum Market 2023-2030 ($M) - Regional Industry Research
14.3 Schistosoma Mekongi Market 2023-2030 ($M) - Regional Industry Research
14.4 Schistosoma Guineensis Market 2023-2030 ($M) - Regional Industry Research
14.5 Schistosoma Haematobium Market 2023-2030 ($M) - Regional Industry Research
15.Europe Drug For Schistosomiasis Market, By Drug Type Market 2023-2030 ($M)
15.1 Praziquantel Market 2023-2030 ($M) - Regional Industry Research
15.2 Metrifonate Market 2023-2030 ($M) - Regional Industry Research
15.3 Biltricide Market 2023-2030 ($M) - Regional Industry Research
15.4 Oxamniquine Market 2023-2030 ($M) - Regional Industry Research
16.APAC Drug For Schistosomiasis Market, By Site Market 2023-2030 ($M)
16.1 Intestinal Market 2023-2030 ($M) - Regional Industry Research
16.2 Urogenital Market 2023-2030 ($M) - Regional Industry Research
17.APAC Drug For Schistosomiasis Market, By Specie Type Market 2023-2030 ($M)
17.1 Schistosoma Mansoni Market 2023-2030 ($M) - Regional Industry Research
17.2 Schistosoma Japonicum Market 2023-2030 ($M) - Regional Industry Research
17.3 Schistosoma Mekongi Market 2023-2030 ($M) - Regional Industry Research
17.4 Schistosoma Guineensis Market 2023-2030 ($M) - Regional Industry Research
17.5 Schistosoma Haematobium Market 2023-2030 ($M) - Regional Industry Research
18.APAC Drug For Schistosomiasis Market, By Drug Type Market 2023-2030 ($M)
18.1 Praziquantel Market 2023-2030 ($M) - Regional Industry Research
18.2 Metrifonate Market 2023-2030 ($M) - Regional Industry Research
18.3 Biltricide Market 2023-2030 ($M) - Regional Industry Research
18.4 Oxamniquine Market 2023-2030 ($M) - Regional Industry Research
19.MENA Drug For Schistosomiasis Market, By Site Market 2023-2030 ($M)
19.1 Intestinal Market 2023-2030 ($M) - Regional Industry Research
19.2 Urogenital Market 2023-2030 ($M) - Regional Industry Research
20.MENA Drug For Schistosomiasis Market, By Specie Type Market 2023-2030 ($M)
20.1 Schistosoma Mansoni Market 2023-2030 ($M) - Regional Industry Research
20.2 Schistosoma Japonicum Market 2023-2030 ($M) - Regional Industry Research
20.3 Schistosoma Mekongi Market 2023-2030 ($M) - Regional Industry Research
20.4 Schistosoma Guineensis Market 2023-2030 ($M) - Regional Industry Research
20.5 Schistosoma Haematobium Market 2023-2030 ($M) - Regional Industry Research
21.MENA Drug For Schistosomiasis Market, By Drug Type Market 2023-2030 ($M)
21.1 Praziquantel Market 2023-2030 ($M) - Regional Industry Research
21.2 Metrifonate Market 2023-2030 ($M) - Regional Industry Research
21.3 Biltricide Market 2023-2030 ($M) - Regional Industry Research
21.4 Oxamniquine Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)2.Canada Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
3.Mexico Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
4.Brazil Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
5.Argentina Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
6.Peru Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
7.Colombia Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
8.Chile Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
9.Rest of South America Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
10.UK Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
11.Germany Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
12.France Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
13.Italy Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
14.Spain Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
15.Rest of Europe Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
16.China Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
17.India Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
18.Japan Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
19.South Korea Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
20.South Africa Drugs For Schistosomiasis Market Revenue, 2023-2030 ($M)
21.North America Drugs For Schistosomiasis By Application
22.South America Drugs For Schistosomiasis By Application
23.Europe Drugs For Schistosomiasis By Application
24.APAC Drugs For Schistosomiasis By Application
25.MENA Drugs For Schistosomiasis By Application
26.Shin Poong Pharma Co , Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Merck Co , Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Bayer Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Egyptian International Pharmaceutical Industry Co Sae, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Cbc Pharma, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Taj Pharmaceutical Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.V H Bhagat Pharmaceutical Pvt Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Vhb Life Science Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Samarth Pharma Pvt Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Shreeji Pharma International, Sales /Revenue, 2015-2018 ($Mn/$Bn)